about
Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database.Musculoskeletal Health of 40-65 Year Old Males and Females in Kosova and the Impact of N05B, A02B (PPI, H2RA), H02AB and Lifestyle Factors on It.Risks and Benefits of Bisphosphonate Therapies.Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.Chronic corticosterone treatment during adolescence has significant effects on metabolism and skeletal development in male C57BL6/N mice.Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis.GLUCOCORTICOID-INDUCED BONE DISEASE: MECHANISMS AND IMPORTANCE IN PEDIATRIC PRACTICE.Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts.Clinical management of osteoporotic vertebral fracture treated with percutaneous vertebroplasty.Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.Evaluation of the effects of photobiomodulation on vertebras in two rat models of experimental osteoporosis.Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.Vitamin D3 Modulates Impaired Crosstalk Between RANK and Glucocorticoid Receptor Signaling in Bone Marrow Cells After Chronic Prednisolone Administration.
P2860
Q37100828-C46CC372-C617-408A-AE57-95D2FDDF69C1Q37470966-F2688BEE-E419-4EFE-9131-8E1D342EBC9BQ38533828-40A7B4EE-576F-49B9-A1E6-B34F6CE44BE7Q38778145-7ACB5C20-3397-4C59-9D32-21A0A6DE152EQ38782800-34E39AF4-9194-4DE7-90DB-A516C48D3EADQ42188123-590127DA-94D3-496E-AA6B-6D9E024CD63DQ42955401-54F70803-0C44-4787-B01F-6855C1CE1666Q46590090-2BEF6FF1-9B1D-4C69-A064-34AB36F33380Q47132058-72DBEC74-20EF-44EC-961D-F08E817673B8Q48029073-7C8FCF36-3CAD-462B-A12F-2D26DF8166A9Q50525169-4AEBB7B8-22A2-484B-ADC8-AE306CE7E464Q51761248-7B6CB1AE-55F0-4186-9E33-627864D47668Q55244612-B6EA7E89-F6E1-45D1-A78C-D782FAEA4603
P2860
description
2015 nî lūn-bûn
@nan
2015 scientific article
@en
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
name
Glucocorticoid-induced osteoporosis
@ast
Glucocorticoid-induced osteoporosis
@en
Glucocorticoid-induced osteoporosis
@nl
type
label
Glucocorticoid-induced osteoporosis
@ast
Glucocorticoid-induced osteoporosis
@en
Glucocorticoid-induced osteoporosis
@nl
prefLabel
Glucocorticoid-induced osteoporosis
@ast
Glucocorticoid-induced osteoporosis
@en
Glucocorticoid-induced osteoporosis
@nl
P2860
P3181
P1433
P1476
Glucocorticoid-induced osteoporosis
@en
P2093
Christian Roux
P2860
P304
P3181
P356
10.1136/RMDOPEN-2014-000014
P407
P50
P577
2015-01-01T00:00:00Z